Navigation Links
Legionnaires' Disease Reported In Sydney: victim seriously ill

Two people ,a man aged 64, and woman aged 81, affected with legionnaires' disease are in Royal North Shore Hospital,Sydney, after being exposed// to the same type of legionella bacteria , NSW Health said..

The man‘s condition is reported to be serious, while the woman’s has improved to a stable state, according to a hospital spokeswoman .

A visit to the cooling towers in the Northbridge area was carried out by the Health officials to identify the source of the exposure, Northern Sydney Central Coast public health unit director, Dr Peter Lewis said. He mentioned that the inspections revealed that appropriate standards have been maintained at the towers,and that there were no risks there for the community. On interviewing the patients’ families, the health officials discovered that they had a "common exposure" after visiting the Northbridge area.

Dr Lewis said the patients were probably exposed to the bacteria about a couple of weeks ago, and there was a chance that more cases would be reported in the days to come.

He also added that the time from exposure to the onset of symptoms is usually around five to six days and that the symptoms of legionnaires' disease resembled those of the flu, including fever, chills, coughing, body and head aches, tiredness, loss of appetite and diarrhoea.

He pointed out that up to 70 cases of the infections were reported in NSW every year.


'"/>




Page: 1

Related medicine news :

1. Another Victim Of Legionnaires Disease
2. NJ Courthouse shut due to Legionnaires Case
3. Legionnaires Outbreak Linked to RAC
4. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
5. Vitamins-The answer to Heart Disease?
6. Link between Constipation and Parkinsons Disease
7. Levels Of Blood Proteins May Help Heart Disease Care
8. New Drug PP188 Helps Sickle Cell Disease
9. Gene Treatment for Heart Disease
10. Legume Consumption Can Cut Heart Disease Risk
11. Link Between Infection And Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: